Details for New Drug Application (NDA): 211346
✉ Email this page to a colleague
The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Summary for 211346
Tradename: | SUCCINYLCHOLINE CHLORIDE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | succinylcholine chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 211346
Physiological Effect | Neuromuscular Depolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 211346
Suppliers and Packaging for NDA: 211346
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 211346 | ANDA | Fresenius Kabi USA, LLC | 63323-943 | 63323-943-10 | 25 VIAL, MULTI-DOSE in 1 CARTON (63323-943-10) / 10 mL in 1 VIAL, MULTI-DOSE (63323-943-21) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
Approval Date: | Nov 20, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription